End Price Gouging for Medications Act
- Last Action
- 6/20/2023
Actions
- 2023-06-20Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-06-20Introduced in Senate
CRS Summary
As of 2023-06-20 (00)
End Price Gouging for Medications Act
This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.
Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
Cosponsors (1)
- Peter Welch (D-VT)
Subjects
- Asia
- Australia
- Canada
- Civil actions and liability
- Europe
- France
- Germany
- Health care costs and insurance
- Health care coverage and access
- Inflation and prices
- Italy
- Japan
- Medicaid
- Medical research
- Medicare
- Military medicine
- Netherlands
- North America
- Oceania
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.